Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xtant Medical is a commercial-stage global medical technology company specializing in the design, development, and commercialization of orthobiologics and spinal fixation systems. Its products are used by orthopedic and neurological surgeons to promote bone healing and treat spinal disease. The company recently launched Trivium™, a next-generation demineralized bone matrix allograft for bone grafting procedures. In Q1 2025 it reported $32.9 million in revenue (up 18% YoY), positive net income ($58K), and raised its full-year revenue guidance to $127–131 million.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xtant Medical.